Cholecalciferol Mylan

Quick links

Choose a section

Quick links to important sections

Advertisements

Cholecalciferol Mylan

Advertisements
Advertisements

Overview of Cholecalciferol Mylan

What is Cholecalciferol Mylan?

Cholecalciferol Mylan is a vitamin supplement that contains cholecalciferol, which is more commonly known as vitamin D3. Vitamin D is a fat-soluble vitamin that plays a fundamental role in the body's ability to maintain mineral balance and skeletal health.

Composition and Mechanism

The active ingredient, cholecalciferol, is the naturally occurring form of vitamin D that the human body synthesizes when skin is exposed to ultraviolet B (UVB) sunlight. Once ingested or produced by the skin, it undergoes metabolic conversion in the liver and kidneys to become the active hormone calcitriol.

Biological Function

Cholecalciferol is essential for several physiological processes, primarily involving the regulation of calcium and phosphate. Its main functions include:

  • Intestinal Absorption: It facilitates the absorption of calcium and phosphorus from the diet through the intestinal wall.
  • Bone Mineralization: It ensures that sufficient minerals are available in the bloodstream to allow for the proper mineralization of bone tissue, supporting the development and maintenance of a strong skeletal system.
  • Neuromuscular Support: It contributes to normal muscle function and the maintenance of the immune system.

Therapeutic Use

This supplement is used to address conditions where vitamin D levels are insufficient. This includes the management of vitamin D deficiency and its prevention in individuals identified as being at high risk. It is also frequently used as an adjunct to specific treatments for bone density loss, ensuring the body has the necessary nutritional components to support bone health.

Advertisements

What side effects are possible with Cholecalciferol Mylan?

Possible Side Effects and Safety Information

The safety profile for Cholecalciferol (Vitamin D3) is principally characterized by effects related to calcium metabolism, particularly when taken in high doses or for extended periods.

Adverse Reactions Scope

Adverse reactions are organized by System Organ Class, as documented in regulatory sources:

  • Metabolism and Nutrition Disorders: Hypercalcaemia (excess calcium in the blood).
  • Renal and Urinary Disorders: Hypercalciuria (excess calcium in the urine).
  • Gastrointestinal Disorders: Constipation, flatulence, nausea, abdominal pain, and diarrhoea.
  • Immune System Disorders: Hypersensitivity reactions (e.g., pruritus, rash, urticaria).

These side effects are typically reported with a frequency of Not Known, meaning their incidence cannot be reliably estimated from available data, and often occur due to long-term high-dose therapy or overdose.

Serious Adverse Reactions

The most serious documented risk is severe hypercalcaemia, which can lead to complications such as renal impairment or failure, and calcification of blood vessels and soft tissues.

Safety-Related Restrictions and Limitations

The use of Cholecalciferol is contraindicated in patients with pre-existing conditions that result in hypercalcaemia, hypercalciuria, severe renal impairment, Nephrolithiasis (kidney stones), or hypersensitivity to the product.

Patients with certain conditions, such as sarcoidosis or renal impairment, must use this medicine with caution and require monitoring of serum calcium and phosphate levels, as they face an increased risk of adverse effects. Safety concerns are particularly associated with prolonged high-dose administration, necessitating clinical oversight.

Advertisements

Overdose and Emergency Response

Cholecalciferol (Vitamin D3) overdose is primarily defined by the development of hypercalcaemia, an officially documented mineral imbalance resulting from excessive intake. The clinical manifestations of overdose described in regulatory labeling include gastrointestinal symptoms such as nausea, vomiting, anorexia (loss of appetite), and constipation, alongside systemic effects like polyuria (increased urination), polydipsia (increased thirst), apathy, confusion, and muscle weakness.

Regulatory documentation specifies that progressive hypercalcaemia can lead to severe and potentially life-threatening outcomes. Documented complications include irreversible renal impairment, the formation of nephrocalcinosis and kidney stones, and serious cardiovascular effects such as cardiac arrhythmias. In severe, untreated cases, overdose is associated with neurological outcomes including stupor and coma. Population-specific notes require caution for patients with renal impairment and during pregnancy, where prolonged hypercalcaemia may pose documented risks to the fetus.

Medical authorities require that emergency medical attention must be sought urgently for progressive symptoms or whenever overdose is suspected, due to the documented risk of permanent organ damage. The officially mandated emergency action is the immediate discontinuation of all Cholecalciferol and calcium intake. Management is supportive and symptomatic, as no specific antidote is known for Colecalciferol toxicity.

Advertisements

Therapeutic Uses of Cholecalciferol Mylan

What Cholecalciferol Mylan Treats: Main Uses and Benefits

Cholecalciferol Mylan is commonly used to help manage symptoms related to systemic imbalance that arise from low vitamin D levels. The main goal is to help with the symptomatic burden and provide support that helps ease the overall symptom burden.

This medication may be part of symptomatic management in conditions where patients experience insufficient Vitamin D.

It is considered relevant for managing symptoms related to physical discomfort and is applied in addressing symptom clusters that may create noticeable physiological strain, such as bone aches, muscle weakness, and fatigue. It is applied in clinical settings that involve nutritional deficiency and is commonly used to help with bone health support and general vitality.

Quick Fact: Support for Fatigue and Aches

This medication offers symptomatic relief that helps improve day-to-day comfort during symptomatic periods. It is often used during phases when symptoms become more noticeable due to lack of sunlight or impaired absorption, providing supportive symptom management.

Regulatory References

  1. NIH MedlinePlus Drug Information on Cholecalciferol
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Cholecalciferol Mylan?

This section outlines the official eligibility and non-eligibility requirements for Cholecalciferol Mylan, strictly based on regulatory documents (SmPC/labeling).

Eligibility Status Populations and Conditions
Eligible Adults, the elderly, and adolescents 12 years and older (Source 1.1). Patients with confirmed Vitamin D deficiency or insufficiency (Source 1.1).
Contraindicated Patients with Hypervitaminosis D, Hypercalcaemia, and Hypercalciuria (Source 1.3). Individuals with Severe renal impairment, Nephrolithiasis (kidney stones), or Nephrocalcinosis (Source 1.4). Patients with a known Hypersensitivity to the active substance or excipients (Source 1.3, 1.5).

Age-Related and Conditional Use Restrictions:

  • Use in children under 12 years is generally not recommended or contraindicated for most medium- and high-strength products, as safety is not established (Source 1.1, 1.5).
  • Caution is required for patients with Sarcoidosis or mild to moderate renal impairment, necessitating close monitoring of calcium levels (Source 1.3, 1.4).
  • Use during Pregnancy is only recommended when a deficiency is confirmed, and high doses must be avoided. Use during Lactation is permitted, but the transfer of Vitamin D to the infant must be accounted for (Source 1.5, 1.8).
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Cholecalciferol Mylan primarily details drug interactions that either modify systemic exposure of the vitamin or potentiate the risk of mineral imbalance.

Interaction Classification (Official Focus) Interacting Substances / Categories
Impaired Absorption (Pharmacokinetic) Bile acid sequestrants (e.g., Cholestyramine, Colestipol), Lipase inhibitors (e.g., Orlistat), and Mineral oil are documented to reduce the amount of Colecalciferol absorbed from the gastrointestinal tract.
Altered Catabolism (Pharmacokinetic) Anticonvulsants (e.g., Phenytoin, Phenobarbital) and Rifampicin are listed as agents that accelerate the metabolic breakdown of Colecalciferol via hepatic enzyme induction, diminishing its systemic levels.
Risk of Hypercalcemia (Pharmacodynamic) Thiazide diuretics (e.g., Hydrochlorothiazide), Digitalis glycosides (e.g., Digoxin), and other Vitamin D analogues are noted to increase the risk of elevated blood calcium levels.

Co-administration with other Vitamin D preparations or analogues is generally restricted due to the combined risk of toxicity. For patients receiving Digitalis glycosides, the potential for hypercalcemia raises the risk of digitalis toxicity and cardiac arrhythmia, necessitating close monitoring. In specific populations, particularly those with renal impairment, co-use of aluminum-containing antacids increases the documented absorption of aluminum, which is a key interaction constraint. The need to separate administration time is documented for certain absorption inhibitors to maintain Colecalciferol exposure.

Advertisements

Mechanism of Action

Hormonal Activation: The Two-Step Metabolic Cascade

The molecule is biologically inert until it undergoes sequential enzyme-driven transformations. This mechanism requires initial 25-hydroxylation in the liver and subsequent final mathbf1alpha-hydroxylation in the kidneys to yield the active hormone, Calcitriol. This two-step process establishes a metabolic bottleneck that dictates the final circulating concentration of the active Calcitriol for systemic action.


Genomic Regulation via the Vitamin D Receptor ( VDR)

The active Calcitriol exerts its effect by functioning as an agonist at the Vitamin D Receptor ( VDR), a nuclear receptor. This interaction leads to transcriptional regulation, meaning it changes the expression of specific genes. The primary consequence is the upregulation of calcium transport proteins in the intestine, which increases the net absorption of dietary calcium and phosphate into the bloodstream.


Endocrine Feedback and Systemic Mineral Balance

The resulting increase in systemic mineral levels engages a regulatory feedback mechanism by suppressing the synthesis and release of Parathyroid Hormone ( PTH). The balanced concentration of circulating calcium and phosphate provides the mineral substrate for the continuous mineralization of newly formed osteoid (bone matrix) and facilitates the calcium gradient required for neuromuscular signal transmission.

Advertisements

Dosage and Administration Information

Cholecalciferol (Vitamin D3) is a fat-soluble vitamin. To maximize absorption, it is generally recommended that you take this medicine with a glass of water, preferably with the main meal of the day. Always follow the instructions provided by your prescribing physician or pharmacist exactly, as the required dose and duration of treatment are highly individualized based on your current vitamin D status (as indicated by blood tests for 25-hydroxyvitamin D [25(OH)D]), age, and specific medical condition.

Dosing and Administration

The dosage of Cholecalciferol is measured in International Units (IU), where 1 µg of vitamin D is equivalent to 40 IU. Your dose will be determined by whether you are treating an established deficiency (loading dose) or maintaining a sufficient vitamin D level (maintenance dose).

Purpose Typical Dosage Range (Adults) Duration
Treatment of Deficiency 1,000 IU to 4,000 IU daily Up to 12 weeks, followed by maintenance
Prevention/Maintenance 800 IU to 2,000 IU daily Long-term, as advised by a doctor

Cholecalciferol is available in various forms, including capsules, tablets, and oral solutions. Tablets and capsules should typically be swallowed whole with water and should not be chewed or crushed unless specified by the product's instructions. If using an oral solution or drops, use the provided measuring syringe or dropper to ensure accurate dosing.

What if you forget a dose?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for a forgotten one, as taking excessive amounts of vitamin D can lead to toxicity.

Advertisements

Recent Clinical Evidence

Cholecalciferol Mylan: Recent Clinical Evidence

This overview describes the structure of the clinical research conducted on cholecalciferol, the active substance in this medicine, focusing on the types of studies performed and documented scientific uncertainties.


Evidence for Correction of Vitamin D Deficiency

The research base for addressing low Vitamin D status is primarily built upon Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies monitor the serum 25( OH) D concentration, the primary blood measure for Vitamin D status, in populations including adults, children, and older adults. Research consistently describes patterns where administration of cholecalciferol was associated with measured increases in this biomarker, helping to track changes where concentrations were below a pre-defined threshold. However, the consistency of these findings can vary, especially in individuals with chronic conditions that affect nutrient absorption.


Supportive Evidence for Bone Health

Studies conducted to evaluate the medicine's role in skeletal health often involve RCTs that use cholecalciferol co-administered with calcium supplements. These trials explore long-term outcomes such as measurements of Bone Mineral Density (BMD) and the rate of new fractures in groups like postmenopausal women. Findings regarding fracture incidence have been described as mixed or inconsistent across systematic reviews. A key limitation is that it is often difficult to isolate the effect of cholecalciferol from co-administered substances when evaluating outcomes.


Research Gaps and Limitations

Beyond biomarkers, research has explored the medicine's association with patient-reported experiences of symptoms like muscle weakness and fatigue; however, the overall strength of evidence for these functional outcomes is limited to small populations or short time frames. The scientific record highlights that long-term effects are not fully established across all contexts, and data for certain high-risk patient groups or those with complex comorbidities remain insufficient to draw broad conclusions.

Key Studies & References

  1. Vitamin D and Bone Health (Guidance from the Society for Endocrinology and review of BMD and fracture evidence)
  2. IOF position statement: vitamin D recommendations for older adults (Focus on muscle strength and fall prevention)
  3. A meta-analysis of 81 randomised trials: Vitamin D supplements do not prevent fractures, falls or improve bone mineral density
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Cholecalciferol Mylan (FAQ)

Q: Can I take this medication if I have a history of heart arrhythmia?

A: Official product information notes caution related to high calcium levels (hypercalcaemia), a potential risk associated with this medicine, particularly when used in high doses or for prolonged periods. An increase in blood calcium may potentially increase the risk of heart rhythm problems.

This concern is especially noted for individuals who are also taking heart medications known as Digitalis glycosides, as this combination may increase the risk of toxicity and cardiac arrhythmia, necessitating close clinical monitoring.

Q: Is it possible to take Cholecalciferol Mylan every other day instead of daily?

A: Official regulatory documents typically list the standard regimen in terms of daily dosing for both deficiency treatment and long-term maintenance.

However, the same product information also states that the required dose and duration of treatment are highly individualized. This means a healthcare provider may recommend a less-than-daily schedule, such as every other day or weekly dosing, based on a person’s current vitamin D status as determined by diagnostic blood tests.

Advertisements

How should Cholecalciferol Mylan be stored and disposed of?

Storage Conditions and Environmental Protection

The medicine must be kept out of the sight and reach of children for safety. Official labeling requires Cholecalciferol capsules to be stored at a controlled temperature, such as below 25 C or not above 30 C, and must be kept from freezing.

To ensure stability against light and moisture, the product must be stored in the original package.

Disposal Instructions

Cholecalciferol Mylan must not be disposed of via wastewater or thrown away with household waste to prevent environmental contamination. When the product is expired or no longer needed, the official procedure is to ask your pharmacist how to throw away any medicines you no longer use so that disposal can be conducted in accordance with local requirements.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cholecalciferol Mylan found in:

A-Z Index: